EARTH SCIENCE TECH, INC.
ETST · Healthcare · $40.8M mkt cap · FY2026 filings · Shallow moat ·
Doesn't clear the bar
The five investor questions
2023–2026: revenue 48537.00 to 35695614.00, increasing; diluted EPS -0.00 to 0.01, increasing.
Median gross margin 41.7% over 9y, variable.
Median ROIC 8.8%, above the 12% hurdle in 50% of years.
Insufficient leverage/coverage inputs to score the balance sheet.
Owner earnings trend unclear, share count growing (dilution).
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
Price vs. owner-earnings value range
- Owner earnings (normalized)
- $3.2M
- Value range / share
- $0.12–$0.12
- Conservative high estimate / share
- $0.12
- Recent price
- $0.14
- Price vs. high estimate
- 16% above high estimate
Conservative range under moat-index@2.0.0: low end 11.1×, high end capped at 18×; 9% discount rate; high-end growth 0% (capped at 4%) using min(5y revenue CAGR, 5y diluted-EPS CAGR), clamped to 0%–4%; maintenance capex uses min(capex, D&A); abstain when D&A is unavailable. This is a disclosed model range, not intrinsic value as fact.
15 years of fundamentals
The business, in plain English
EARTH SCIENCE TECH, INC. booked $35.7M of revenue in FY2026 in the Healthcare sector and kept 71.4% of it as gross profit — a high-margin business by that measure. After every other cost, 10.2% of each revenue dollar reached the bottom line.
Across the filed record, revenue grew from $22421 (FY2012) to $35.7M (FY2026) — about 69.3% a year compounded over 14 years.
It earned 56.6% on invested capital in FY2024, with a median of −573.1% across 4 filed years. The Returns on Capital filter above scores it 34/100.
The balance sheet carried $179488 of total debt in FY2025.
The share count rose 4248.1% between FY2012 and FY2026 — existing owners have been diluted over the record. Capital Discipline scores it 24/100.
This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.
Gaps in a line mean that item isn’t in ETST’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.
Moat Score history
Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars
- Methodology upgraded moat-index@1.2.0tomoat-index@2.0.0 — readings across versions aren’t comparedJul 20, 2026
Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.
Track record
How EARTH SCIENCE TECH, INC.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.
How to read this: each dot is what the engine would have scored ETST on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.
Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The price path is a total-return (dividends reinvested) index built from the same data the forward returns use; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.
What followed, in the years it rated Wide
In the reconstructed history shown, ETST did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.
Healthcare context
#255 of 736 scored Healthcare companies, ranked by Moat Score.
Nearest peers by Moat Score
- #253LUCY INNOVATIVE EYEWEAR, INC.46.2 out of 100, Shallow moatShallow moat
- #254NEOG Neogen Corporation46.1 out of 100, Shallow moatShallow moat
- #256TRNS TRANSCAT INC46.0 out of 100, Shallow moatShallow moat
- #257TEVA TEVA PHARMACEUTICAL INDUSTRIES LIMITED46.0 out of 100, Shallow moatShallow moat
Compare ETST with its nearest peers →All Healthcare companies on the Index →
Common questions about ETST
- Does EARTH SCIENCE TECH, INC. have an economic moat?
- Based on its FY2026 SEC filings, the Moat Index scores EARTH SCIENCE TECH, INC. (ETST) 46.1 out of 100 — a Shallow moat. The five questions behind that score begin at 20% each; if exactly one genuinely lacks data, the other four weights are renormalized and disclosed. revenue and EPS trend 85, pricing power 41, returns on capital 34, balance-sheet safety not measurable from the filings, capital discipline 24.
- Is ETST trading below the conservative owner-earnings estimate?
- The owner-earnings value range is $0.12–$0.12 per share. It capitalizes normalized owner earnings at a 9% rate; the low end assumes 0% growth and the high end uses 0% growth, capped at 4% and 18×. Versus a recent price of $0.14, that is 16% above high estimate relative to the high estimate. This is a conservative educational estimate from primary SEC filings, not intrinsic value as a fact or investment advice.
- How has ETST's Moat Score changed over time?
- The record logs 8 readings since Jul 17, 2026; the latest reads 46.1 out of 100 (shallow moat). No tier changes on record yet. (A methodology upgrade on Jul 20, 2026 re-based the score; readings across engine versions aren't compared.) The history is append-only — readings are only ever added, never rewritten.